Indication1
DUPIXENT is indicated as an add-on therapy with intranasal corticosteroids for the treatment of adults with severe CRSwNP for whom therapy with systemic corticosteroids and/or surgery do not provide adequate disease control.
CRS, chronic rhinosinusitis; CRSwNP, chronic rhinosinusitis with nasal polyps.
| TARGET Type 2 inflammation1-3 | TREAT full spectrum of symptoms1,12,13 | CONTROL with less surgery or fewer steroids1,13 |
| Find out how > | See the data > | Learn more > |